Life Science & Biotech

Appeals court ruling upholds Lilly's Evista patents

September 1, 2010
Bloomberg News
Eli Lilly and Co. won a court ruling Wednesday that blocks plans by Teva Pharmaceutical Industries Ltd. to sell a generic version of the Evista osteoporosis treatment before March 2014.
More

Local economic espionage case full of intrigue

September 1, 2010
Cory Schouten
The government's allegations read like a spy novel: Dr. Ke-xue "John" Huang lands a job at Indianapolis-based Dow AgroSciences and over five years works himself into a position of trust, with access to trade secrets and processes the company has invested $300 million to develop.
More

Ex-Dow Agro scientist's espionage indictment unsealed

August 31, 2010
 IBJ Staff
A federal indictment unsealed Tuesday in Indianapolis charged 45-year-old Ke-xue "John" Huang with theft and attempted theft of trade secrets to benefit a foreign government.
More

Endocyte's $86M IPO plan a boon for Indiana, investors

August 28, 2010
Greg Andrews
Venture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital, Clarian Health Ventures and the Indiana Future Fund.
More

Cancer drug developer Endocyte files for IPO

August 18, 2010
Scott Olson
The company, headquartered at Purdue Research Park, said the number of shares to be offered and their price range have yet to be determined.
More

Biomet investing $26M to expand, create nearly 280 jobs

August 13, 2010
 IBJ Staff
Orthopedics giant Biomet Inc. plans to invest $26 million to grow operations in its hometown of Warsaw, adding 278 jobs by the end of 2012.
More

Indiana universities offer cash incentives for technology transfer

August 7, 2010
 IBJ Staff
The Indiana Clinical and Translational Sciences Institute awarded $750,000 to 10 teams of researchers.
More

Dow Agro boosts sales, profit in second quarter

August 3, 2010
 IBJ Staff and Bloomberg News
Indianapolis-based Dow AgroSciences improved sales and profit in its second quarter thanks to higher volumes and lower costs, the company said Tuesday morning.
More

Indiana life sciences companies capture more venture capital money in first half of 2010

July 31, 2010
 IBJ Staff
Venture dollars for Hoosier companies are still few, but the flow of deals is picking up.
More

Lilly's second-quarter profits surge 16 percent

July 22, 2010
J.K. Wall
Indianapolis-based drugmaker Eli Lilly and Co. recorded profits of $1.3 billion, or $1.22 per share, during the three months ended June 30, even after paying $27 million in severance to laid off employees.
More

New rules raise stakes for Lilly drug

July 21, 2010
J.K. Wall
Drugmakers testing experimental Alzheimer’s medicines—including Eli Lilly and Co.—got good news last week when the National Institute on Aging and the Alzheimer’s Association proposed new guidelines to make earlier diagnoses of the disease.
More

Lilly's Lechleiter: No change in plans

July 7, 2010
J.K. Wall
The global financial press keeps asking John Lechleiter for his end-game strategy to survive Eli Lilly and Co.'s nightmarish patent challenges. And, like a broken record, the Lilly CEO keeps giving the same answer: pipeline, pipeline, pipeline—no mega-merger.
More

Marcadia enlists Lilly to help develop new diabetes drug

June 28, 2010
J.K. Wall
The two companies will jointly develop a short-acting glucagon drug, which they hope proves more convenient than Lilly’s current Glucagon for patients with severe hypoglycemia.
More

Q&A

June 23, 2010
J.K. Wall
David Stocum is the director of the Center for Regenerative Biology and Medicine at the IUPUI School of Science. He and his team are studying how amphibians regenerate parts of their bodies to see if there are ways to induce humans to regenerate tissue that is lost or damaged. The center has about 20 researchers and funding of about $14 million to fuel its quest.
More

Indiana's biggest private companies majored in the basics in 2009Restricted Content

June 19, 2010
Martha P. Allan
Health care, plastics, other fundamental consumer needs kept some companies on upswings.
More

Promising ethanol yeast nears market launchRestricted Content

June 19, 2010
Chris O'Malley
A firm that may have developed a breakthrough yeast for ethanol production has landed new investment and high-octane board members. Two-year-old Xylogenics Inc. also says it plans to license its first bioengineered yeast later this year.
More

AIT Labs moving headquarters, adding 160 jobs

June 17, 2010
Scott Olson
The Indianapolis-based forensics, clinical and pharmaceutical testing firm, led by CEO Michael Evans, plans to invest $74 million to acquire and equip an existing 90,000-square-foot building in Woodland Corporate Park near West 79th Street and Interstate 465.
More

UPDATE: Commission approves City Market funding

June 16, 2010
Scott Olson
The Metropolitan Development Commission voted Wednesday afternoon to release nearly $4 million to improve the historic building in downtown Indianapolis.
More

Indiana Seed Fund nearing end of $6 million stashRestricted Content

June 5, 2010
Chris O'Malley
Having invested in 10 companies since 2005 and with its $6 million pot of money running low, the Indiana Seed Fund is nearing a crossroads.
More

OrthoWorx initiative names executive director

June 3, 2010
 IBJ Staff
Not-for-profit launched last year by BioCrossroads and Indiana's orthopedic companies names Zimmer Inc. executive Brad Bishop to lead the initiative.
More

Cancer researcher battling Semafore in courtRestricted Content

May 29, 2010
Chris O'Malley
Former collaborator alleges firm breached its agreement with him and refused to pay royalty income.
More

Biopharma fueling boom in refrigerated warehousing

May 29, 2010
Chris O'Malley
In the past few years, a handful of cold storage facilities have sprouted locally by playing to Indianapolis' strengths in warehousing and life sciences.
More

Indianapolis startup attacks Alzheimer's diseaseRestricted Content

May 29, 2010
Norm Heikens
AgeneBio Inc. this month landed a $300,000 investment from the Indiana Seed Fund to fund operations, bolster its intellectual property, and begin learning how to make a drug into a once-a-day pill.
More

Bioanalytical Systems reports loss in second quarter

May 17, 2010
 IBJ Staff
Bioanalytical Systems Inc. narrowed its losses in the second fiscal quarter despite a 2 percent drop in revenue, the West Lafayette-based contract research firm said late last week.
More

Bioanalytical Systems names new chief executive

May 14, 2010
 IBJ Staff
West Lafayette-based Bioanalytical Systems Inc. has promoted Anthony S. Chilton to CEO following the retirement of top executive Richard M. Shepperd earlier this year.
More
Page  << 11 12 13 14 15 16 17 18 19 20 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT